INTERNATIONAL PATENT: NOVIMMUNE SA FILES APPLICATION FOR "METHOD OF TREATING DISEASE USING ANTI-CD47 X ANTI-MESOTHELIN ANTIBODIES AS A SOLE AGENT AND IN COMBINATION WITH ANTI-PD-1 ANTIBODIES"

GENEVA, June 10 -- NOVIMMUNE SA (Chemin du Pre-Fleuri 15Plan-Les-Ouates1228 Geneva) filed a patent application (PCT/EP2024/083760) for "METHOD OF TREATING DISEASE USING ANTI-CD47 X ANTI-MESOTHELIN ANTIBODIES AS A SOLE AGENT AND IN COMBINATION WITH ANTI-PD-1 ANTIBODIES" on Nov 27, 2024. With publication no. WO/2025/114357, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SARO SUAREZ, Jose Maria (c/o NovImmune SAChemin du Pre-Fleuri 15, Plan-Les-Ouates1228 Geneva), FERLIN, Walter G. (c/o Novimmune SAChemin du Pre-Fleuri 15, ...